Bruton Tyrosine Kinase Inhibitors decrease phosphorylation levels and pro-inflammatory cytokine production in healthy controls and relapse-remitting MS patient peripheral blood mononuclear cells

Rochelle Benoit,Neva Fudge,Craig Moore

MULTIPLE SCLEROSIS JOURNAL(2023)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要